Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR‑520a‑3p/EGFR axis
- Type
- Retraction
- Notice date
- 9/1/2025 0:00
- Journal
- Molecular Medicine Reports
- Publisher
- Spandidos
- Notice DOI
- 10.3892/mmr.2025.13669
- Original paper DOI
- 10.3892/mmr.2019.10363
Reasons
- Concerns/Issues about Data
- Euphemisms for Plagiarism
- Investigation by Journal/Publisher
- Investigation by Third Party
- Plagiarism of Data